Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colloidal bismuth sub-citrate plus esomeprazole, amoxicillin and metronidazole for Helicobacter pylori eradication in children
2013-003931-30Phase 4Completed
- Sponsor
- Queen Fabiola Children's University Hospital
- Start
- Jan 2014
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bismuth subcitrate in Helicobacter pylori infection, sponsored by Queen Fabiola Children's University Hospital. Primary endpoint: Helicobacter pylori eradication by 13C-urea breath test. Started Jan 2014; status: completed.
02
Drugs
bismuth subcitrate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on 2013-003931-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003931-30.